Sign up to save your podcasts
Or
Share Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?
Host: Joshua E. Reuss, MD
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
View all episodes
Host: Joshua E. Reuss, MD
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.